naftopidil has been researched along with Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akasaka, T; Fujishima, M; Funaki, H; Hirano, S; Kudou, T; Ohinata, M; Suzuki, A | 1 |
| Fujita, Y; Inamura, M; Koyama, T; Miyoshi, T; Ohashi, Y; Ohki, K; Okamoto, S; Oshika, T; Sakabe, I; Takahashi, K; Yasuma, T | 1 |
2 other study(ies) available for naftopidil and Syndrome
| Article | Year |
|---|---|
[Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Chronic Disease; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Pelvic Pain; Piperazines; Prostatitis; Quality of Life; Surveys and Questionnaires; Syndrome; Time Factors | 2010 |
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha(1)-adrenoceptor antagonist.
Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Female; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin | 2007 |